Clinical Trials Directory

Trials / Completed

CompletedNCT01229033

Ablating Atrial Tachycardias Occuring During Ablation of Complex Fractionated Electrograms in Persistent AF

Ablating Atrial Tachycardias Occuring During Ablation of Complex Fractionated Electrograms in Persistent AF - ATTAC CFAE Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
186 (estimated)
Sponsor
Deutsches Herzzentrum Muenchen · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Catheter ablation has proven to be an effective treatment option in patients suffering from symptomatic persistent atrial fibrillation (AF). Catheter ablation consists of two major steps: (1) Isolation of pulmonary veins to abolish the trigger of atrial fibrillation and (2) modification of left atrial and eventually right atrial substrate by ablation of complex fractionated atrial electrograms (CFAE). CFAE are mainly found at the ostia of the pulmonary veins, around the left atrial appendage, at the mitral annulus and the septum. When ablating CFAE 40-65% of the patients show a regularization of AF to an atrial tachycardia (AT) that can be macro- or micro-reentrant (localized re-entry). Until now the significance of the AT is unclear. In the following study we examine the hypothesis that an ablation of AT occuring during CFAE ablation (group 1) significantly improves outcome defined as freedom of atrial arrhythmia (AF or AT) compared to patients that are cardioverted when AF has regularized to AT (group 2).

Conditions

Interventions

TypeNameDescription
PROCEDUREAblationAblation of atrial tachycardia
PROCEDURECardioversionCardioversion of atrial tachycardia

Timeline

Start date
2010-01-01
Primary completion
2013-01-01
Completion
2014-01-01
First posted
2010-10-27
Last updated
2017-04-11

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT01229033. Inclusion in this directory is not an endorsement.